by 
Personalized Medicine Market Key Takeaway
- North America has accounted revenue share of over 45.33% in 2024.
- The Asia Pacific region is growing faster during the forecast period.
- By product, the personalized nutrition and wellness segment has captured a revenue share of over 48.40% in 2024.
- The personalized medicine therapeutics segment is growing at the fastest CAGR of 8.10% from 2025 to 2034.
- By Application, the oncology segment contributed the largest market share of 41.96% in 2024.
- By End User, the hospitals segment contributed the highest market share of 38.63% in 2024.
Market Overview
The personalized medicine market is experiencing significant growth, driven by advancements in genomics, biotechnology, and digital health technologies. Personalized medicine focuses on tailoring medical treatment to individual characteristics, including genetic makeup, lifestyle, and environment, offering more precise and effective healthcare solutions.
Increasing demand for targeted therapies, especially in oncology and chronic disease management, is a key factor propelling the market. The integration of artificial intelligence and big data analytics has further enhanced the capabilities of personalized diagnostics and treatments, allowing for earlier detection, better monitoring, and optimized therapeutic outcomes.
Growing awareness of individualized care, along with rising adoption of companion diagnostics, is expanding the market across both developed and emerging economies. Hospitals, research institutions, and pharmaceutical companies are increasingly investing in personalized solutions, supported by favorable government policies and funding initiatives.
The market is also being shaped by the rising prevalence of lifestyle-related diseases and the global shift toward preventive and precision healthcare. As innovation continues in areas such as pharmacogenomics, biomarker development, and AI-enabled clinical tools, personalized medicine is poised to play a central role in the future of global healthcare delivery.
Personalized Medicine Market Growth Factors
- Advancements in Genomics and Biotechnology: Rapid developments in genomic sequencing, bioinformatics, and molecular diagnostics are enabling more precise identification of disease markers, allowing for highly targeted and individualized treatment approaches.
- Rising Demand for Targeted and Preventive Therapies: The increasing prevalence of chronic and lifestyle-related diseases has driven the demand for therapies tailored to individual patient profiles, enhancing treatment effectiveness while minimizing side effects.
- Integration of AI and Data Analytics in Healthcare: The adoption of artificial intelligence and machine learning in clinical decision-making is accelerating the development of predictive models, personalized treatment plans, and real-time monitoring solutions, significantly boosting the efficiency and scalability of personalized medicine.
Personalized Medicine Market Companies
- Illumina Inc.
- Precision Biologics
- Danaher Corporation
- GE Healthcare
- Celera Diagnostics LLC
- Decode Genetics Inc.
- Exact Sciences Corporation
- IBM Corporation
- Exagen Inc.
- Biogen
Recent Developments
- Illumina, Inc. announced a national level pilot program agreement with the Belgian Society of Medical Oncology in February 2021 to evaluate Comprehensive Genomic Profiling in advanced metastatic cancer patients.
- Personalized Lifestyle Medicine Center, a clinical research laboratory and patient clinic, opened Gig Harbor, Washington, in January 2019. The Center will test a tailored lifestyle medicine approach, tailoring therapy treatments to each patient’s unique needs.
- PERSONA nutrition, a division of Vitamin Packs, Inc. will launch new vitamin supplements for individualized health in March 2019. The most recent supplements include a combination product to help subscribers minimize the number of capsules they take each day, as well as new vegan soft gels and a program tailored to bariatric patients.
- FabRx will release the M3DIMAKER 3D Printer for customized medicine in 2020. This gadget can produce printlets, which are 3D pills containing a precise dose of medicine. Furthermore, this printer is capable of combining multiple medications into a single tablet as prescribed by medical authorities.
- Infosys will introduce an SAP-based personalized medicine solution for pharmaceutical companies in 2020. This technology aids pharma companies in the preparation of customized medicines based on patient needs and drug quantities.
- Precision Therapeutics Inc. and Helomics Holding Corporation announced a merger agreement in June 2018. This agreement will bring together both companies’ precision diagnostic and integrated contract research organizations’ capabilities, with the goal of improving patient care and advancing the development of new clinical products and technology for the treatment of cancer and other diseases.
Segments Covered in the Report
By Product
- Personalized Medicine Diagnostics
- Genetic Testing
- DTC Diagnostics
- Esoteric Lab Services
- Esoteric Lab Tests
- Personalized Medicine Therapeutics
- Pharmaceutical
- Genomic Medicine
- Medical Devices
- Personalized Medical Care
- Telemedicine
- Health Information Technology
- Personalized Nutrition and Wellness
- Retail Nutrition
- Complementary & Alternative Medicine
By Application
- Oncology
- CNS
- Immunology
- Respiratory
- Liver
- Rhematology
- Others
By End-use
- Hospitals
- Diagnostic Centers
- Research & Academic Institutes
- Others
By Technology
- Big Data Analytics
- Artificial Intelligence
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Companion Diagnostics
- Genetics
- Liquid Biopsy
- Others (Predictive Modelling, Imaging, etc.)
By Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
